Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Packard BioScience Company was a prominent developer and manufacturer of analytical instruments, software, and reagents for the life sciences and drug discovery industries. The company was best known for its automated liquid handling systems, scintillation counters, and microplate readers, which became industry standards for high-throughput screening (HTS). Its product lines, including the TopCount and MultiPROBE systems, were critical for genomic and proteomic research. In 2001, Packard BioScience was acquired by PerkinElmer for approximately $650 million, a move that solidified PerkinElmer's position as a leader in the drug discovery tools market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Packard Bioscience.